Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells
Yu Chuan Liu, Se Lim Kim, Young Ran Park, Soo-Teik Lee, Sang Wook Kim
Intest Res. 2017;15(2):174-181.   Published online 2017 Apr 27     DOI: https://doi.org/10.5217/ir.2017.15.2.174
Citations to this article as recorded by Crossref logo
ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
Xiao‐Han Jin, Yong‐Sheng Jia, Ye‐Hui Shi, Qiu‐Ying Li, Shi‐Qi Bao, Wen‐Ping Lu, Zhong‐Sheng Tong
Journal of Cellular Biochemistry.2019; 120(2): 1386.     CrossRef
Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
Mona Dawood, Edna Ooko, Thomas Efferth
Frontiers in Pharmacology.2019;[Epub]     CrossRef
Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
Luksana Chaiswing, William H. St. Clair, Daret K. St. Clair
Antioxidants & Redox Signaling.2018; 29(13): 1237.     CrossRef
Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression
Wamidh H. Talib, Lina T. Al Kury
Biomedicine & Pharmacotherapy.2018; 107: 1488.     CrossRef
Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer
Sen Jiang, Kun Zhang, Yan He, Xuetao Xu, Dongli Li, Shupeng Cheng, Xi Zheng
RSC Advances.2018; 8(5): 2768.     CrossRef
The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
Xin Jin, Jianping Zhou, Zhenhai Zhang, Huixia Lv
Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup3): S931.     CrossRef